This page contains a Flash digital edition of a book.
HEALTHLINE


The extracellular matrix glues the body together, holds it up against gravity, gives it and all its organs their unique shapes, and cushions cells and organs by absorbing water.


Symptoms and Causes


Because the proteins of the extracellular matrix vary in structure and function and because different autoimmune disorders cause the immune system to selectively attack different proteins, each of the autoimmune connective tissue disorders has its own unique set of symptoms. The names of the various disorders reflect these symp- toms. The formal name of the most common form of lupus, systemic lupus erythematosus, for example, describes a disc-shaped skin rash that is characteristically red (erythematous) and heals from the inside out. During the thirteenth century, a physician named Rogerius likened the physical appearance of this rash to the bite of a wolf and gave the condition the name lupus, which means “wolf” in Latin. The word “systemic” describes the potential for the ailment to affect any organ system in the body, producing fever, joint pain, fatigue, sores in the nose or mouth, painful breathing, hair loss, skin rashes, abdominal pain, epilepsy, and even psychoses.


Different names are applied to some lupus cases, but the disease


process in all types is the same. Lupus can be very mild and involve only the skin. Patients at this end of the spectrum of the disease are said to have discoid lupus, and while most of them will not progress to more severe forms, there is no way to predict the long-term course of the disease. Drug-induced lupus can be triggered by prolonged use of hydralazine (a drug used to treat high blood pressure), procainamide and quinidine (drugs used to treat irregular heart- beats), isoniazid (a drug used to treat tuberculosis), and less com- monly by over two dozen other drugs. Neonatal lupus affects new- born children of mothers with lupus.


Who Is at Risk?


How common is lupus? Estimates place the number of Americans with the disease at less than one-half of one percent, and each year, more than 16,000 new cases are reported in the United States. Worldwide, close to 5 million people have some form of lupus. Racial differences in susceptibility occur, with black people and Asians being at higher risk than white people. Lupus, like many other autoimmune diseases, is also more common in women, especially during childbearing years and menopause, suggesting that the fe- male XX combination of chromosomes renders the body more sus- ceptible to immune attack than the male XY pair does. Susceptibility to acquired connective tissue disorders can also run in families, but genetic predisposition alone does not produce signs or symptoms of these diseases, which are activated by external triggers. While the triggers in acquired connective tissue disorders


T H E E L K S M A G A Z I N E 21


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93